The World Health Organization is looking for a dozen experts to join a new technical advisory group to help deliver guidance on best practices for clinical trials as outlined in the World Health Assembly’s May 2022 resolution on this topic.
The WHA resolution is aimed at improving the quality, efficiency and transparency of drug, device and vaccine clinical trials worldwide. It called for the development of new guidance, as needed, on measures that WHO member states could apply to strengthen their respective clinical trial infrastructure in normal times as well as during a public health emergency of international concern
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?